---
title: "Defu Technology: Shareholders plan to reduce their holdings by no more than 0.13% of the company's shares"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/258895990.md"
description: "Defu Technology announced that the company's controlling shareholder, actual controller, and director Ma Ke plans to reduce his holdings by no more than 803,040 shares, accounting for 0.13% of the company's total share capital; directors and senior management Jiang Yang, Jin Rongtao, and Gong Kaikai plan to reduce their holdings by no more than 3,325 shares, 8,750 shares, and 4,130 shares, respectively. The reason for the reduction is personal funding needs, and the method of reduction will be through centralized bidding transactions, with the reduction period being within 3 months after 15 trading days from the date of the announcement"
datetime: "2025-09-25T13:05:50.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/258895990.md)
  - [en](https://longbridge.com/en/news/258895990.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/258895990.md)
generator: "portal-rs"
---

# Defu Technology: Shareholders plan to reduce their holdings by no more than 0.13% of the company's shares

Defu Technology announced that the company's controlling shareholder, actual controller, and director Ma Ke plans to reduce his holdings by no more than 803,040 shares, accounting for 0.13% of the company's total share capital; directors and senior executives Jiang Yang, Jin Rongtao, and Gong Kaikai plan to reduce their holdings by no more than 3,325 shares, 8,750 shares, and 4,130 shares, respectively. The reason for the reduction is personal funding needs, the method of reduction is centralized bidding trading, and the reduction period is within three months after 15 trading days from the announcement date

### Related Stocks

- [301511.CN](https://longbridge.com/en/quote/301511.CN.md)

## Related News & Research

- [Palvella Therapeutics COO Kathleen Goin reports sale of 4,302 common shares worth $654,184.41](https://longbridge.com/en/news/296530942.md)
- [Tech tries a new message: You'd love data centers if China wasn't making you hate data centers](https://longbridge.com/en/news/296638983.md)
- [JDC: Record growth in turnover and EBITDA, with strong outlook driven by new regulation and AI](https://longbridge.com/en/news/296247395.md)
- [Tvardi Therapeutics: TTI-109, an oral STAT3 inhibitor, targets unmet needs in UC with promising safety and efficacy data](https://longbridge.com/en/news/296388332.md)
- [09:15 ETSEC's Proposed E-Delivery Rule Signals a New Era in Customer Communications](https://longbridge.com/en/news/296361991.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**